2,3,7,8-Tetrachlorodibenzo-p-dioxin-mediated disruption of the CD40 ligand-induced activation of primary human B cells

Toxicology and Applied Pharmacology

Volumn 255, Issue 3, 2011, Pages 251-260

  Lu, Haitian ^a   Crawford, Robert B ^a   Kaplan, Barbara L F ^a   Kaminski, Norbert E ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

Cell activation; Human B cell; Immunotoxicology; TCDD

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; B LYMPHOCYTE INDUCED MATURATION PROTEIN 1; B7 ANTIGEN; CD40 LIGAND; CD69 ANTIGEN; CD86 ANTIGEN; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE B; TRANSCRIPTION FACTOR PAX5;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY PRODUCTION; ARTICLE; B LYMPHOCYTE ACTIVATION; B LYMPHOCYTE DIFFERENTIATION; CELL VIABILITY; CONTROLLED STUDY; ENZYME ACTIVATION; FEMALE; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PROTEIN EXPRESSION;

ANIMALS; B-LYMPHOCYTES; CD40 LIGAND; CELLS, CULTURED; COCULTURE TECHNIQUES; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; MICE; MICE, INBRED C57BL; RANDOM ALLOCATION; TETRACHLORODIBENZODIOXIN;

MUS;

EID: 80052380668     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2011.06.026     Document Type: Article

References (46)

1. Andjelic S., Hsia C., Suzuki H., Kadowaki T., Koyasu S., Liou H.C. Phosphatidylinositol 3-kinase and NF-kappa B/Rel are at the divergence of CD40-mediated proliferation and survival pathways. J. Immunol. 2000, 165:3860-3867.
2. Arpin C., Dechanet J., Van Kooten C., Merville P., Grouard G., Briere F., Banchereau J., Liu Y.J. Generation of memory B cells and plasma cells in vitro. Science 1995, 268:720-722.
3. Baccarelli A., Mocarelli P., Patterson D.G., Bonzini M., Pesatori A.C., Caporaso N., Landi M.T. Immunologic effects of dioxin: new results from Seveso and comparison with other studies. Environ. Health Perspect. 2002, 110:1169-1173.
4. Batlle A., Papadopoulou V., Gomes A.R., Willimott S., Melo J.V., Naresh K., Lam E.W., Wagner S.D. CD40 and B-cell receptor signalling induce MAPK family members that can either induce or repress Bcl-6 expression. Mol. Immunol. 2009, 46:1727-1735.
5. Bishop G.A. The multifaceted roles of TRAFs in the regulation of B-cell function. Nat. Rev. Immunol. 2004, 4:775-786.
6. Bishop G.A., Hostager B.S. Signaling by CD40 and its mimics in B cell activation. Immunol. Res. 2001, 24:97-109.
7. Bishop G.A., Hostager B.S. The CD40-CD154 interaction in B cell-T cell liaisons. Cytokine Growth Factor Rev. 2003, 14:297-309.
8. Calame K. Activation-dependent induction of Blimp-1. Curr. Opin. Immunol. 2008, 20:259-264.
9. Calo V., Migliavacca M., Bazan V., Macaluso M., Buscemi M., Gebbia N., Russo A. STAT proteins: from normal control of cellular events to tumorigenesis. J. Cell. Physiol. 2003, 197:157-168.
10. De Abrew K.N., Kaminski N.E., Thomas R.S. An integrated genomic analysis of aryl hydrocarbon receptor-mediated inhibition of B-cell differentiation. Toxicol. Sci. 2010, 118:454-469.
11. Dooley R.K., Holsapple M.P. Elucidation of cellular targets responsible for tetrachlorodibenzo-p-dioxin (TCDD)-induced suppression of antibody responses: I. The role of the B lymphocyte. Immunopharmacology 1988, 16:167-180.
12. Dooley R.K., Morris D.L., Holsapple M.P. Elucidation of cellular targets responsible for tetrachlorodibenzo-p-dioxin (TCDD)-induced suppression of antibody responses: II. The role of the T-lymphocyte. Immunopharmacology 1990, 19:47-58.
13. Elgueta R., Benson M.J., de Vries V.C., Wasiuk A., Guo Y., Noelle R.J. Molecular mechanism and function of CD40/CD40L engagement in the immune system. Immunol. Rev. 2009, 229:152-172.
14. Farraj A.K., Harkema J.R., Kaminski N.E. Allergic rhinitis induced by intranasal sensitization and challenge with trimellitic anhydride but not with dinitrochlorobenzene or oxazolone in A/J mice. Toxicol. Sci. 2004, 79:315-325.
15. Gallagher E., Enzler T., Matsuzawa A., Anzelon-Mills A., Otero D., Holzer R., Janssen E., Gao M., Karin M. Kinase MEKK1 is required for CD40-dependent activation of the kinases Jnk and p38, germinal center formation, B cell proliferation and antibody production. Nat. Immunol. 2007, 8:57-63.
16. Greenwald R.J., Freeman G.J., Sharpe A.H. The B7 family revisited. Annu. Rev. Immunol. 2005, 23:515-548.
17. Hanissian S.H., Geha R.S. Jak3 is associated with CD40 and is critical for CD40 induction of gene expression in B cells. Immunity 1997, 6:379-387.
18. Holsapple M.P., Morris D.L., Wood S.C., Snyder N.K. 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced changes in immunocompetence: possible mechanisms. Annu. Rev. Pharmacol. Toxicol. 1991, 31:73-100.
19. Kaplan B.L., Lawver J.E., Karmaus P.W., Ngaotepprutaram T., Birmingham N.P., Harkema J.R., Kaminski N.E. The effects of targeted deletion of cannabinoid receptors CB1 and CB2 on intranasal sensitization and challenge with adjuvant-free ovalbumin. Toxicol. Pathol. 2010, 38(3):382-392.
20. Kim H.A., Kim E.M., Park Y.C., Yu J.Y., Hong S.K., Jeon S.H., Park K.L., Hur S.J., Heo Y. Immunotoxicological effects of Agent Orange exposure to the Vietnam War Korean veterans. Ind. Health 2003, 41:158-166.
21. Lu Y.C., Wu Y.C. Clinical findings and immunological abnormalities in Yu-Cheng patients. Environ. Health Perspect. 1985, 59:17-29.
22. Lu H., Crawford R.B., North C.M., Kaplan B.L., Kaminski N.E. Establishment of an immunoglobulin m antibody-forming cell response model for characterizing immunotoxicity in primary human B cells. Toxicol. Sci. 2009, 112:363-373.
23. Lu H., Crawford R.B., Suarez-Martinez J.E., Kaplan B.L., Kaminski N.E. Induction of the aryl hydrocarbon receptor-responsive genes and modulation of the immunoglobulin M response by 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin in primary human B cells. Toxicol. Sci. 2010, 118(1):86-97.
24. McHeyzer-Williams M.G., McHeyzer-Williams L.J., Fanelli Panus J., Bikah G., Pogue-Caley R.R., Driver D.J., Eisenbraun M.D. Antigen-specific immunity. Th cell-dependent B cell responses. Immunol. Res. 2000, 22:223-236.
25. North C.M., Crawford R.B., Lu H., Kaminski N.E. Simultaneous in vivo time course and dose response evaluation for TCDD-induced impairment of the LPS-stimulated primary IgM response. Toxicol. Sci. 2009, 112:123-132.
26. North C.M., Crawford R.B., Lu H., Kaminski N.E. 2,3,7,8-tetrachlorodibenzo-p-dioxin-mediated suppression of toll-like receptor stimulated B-lymphocyte activation and initiation of plasmacytic differentiation. Toxicol. Sci. 2010, 116:99-112.
27. Ochiai K., Katoh Y., Ikura T., Hoshikawa Y., Noda T., Karasuyama H., Tashiro S., Muto A., Igarashi K. Plasmacytic transcription factor Blimp-1 is repressed by Bach2 in B cells. J. Biol. Chem. 2006, 281:38226-38234.
28. Ochiai K., Muto A., Tanaka H., Takahashi S., Igarashi K. Regulation of the plasma cell transcription factor Blimp-1 gene by Bach2 and Bcl6. Int. Immunol. 2008, 20:453-460.
29. Park S.J., Yoon W.K., Kim H.J., Son H.Y., Cho S.W., Jeong K.S., Kim T.H., Kim S.H., Kim S.R., Ryu S.Y. 2,3,7,8-Tetrachlorodibenzo-p-dioxin activates ERK and p38 mitogen-activated protein kinases in RAW 264.7 cells. Anticancer. Res. 2005, 25:2831-2836.
30. Rousset F., Garcia E., Defrance T., Peronne C., Vezzio N., Hsu D.H., Kastelein R., Moore K.W., Banchereau J. Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes. Proc. Natl. Acad. Sci. U. S. A. 1992, 89:1890-1893.
31. Rui L., Healy J.I., Blasioli J., Goodnow C.C. ERK signaling is a molecular switch integrating opposing inputs from B cell receptor and T cell cytokines to control TLR4-driven plasma cell differentiation. J. Immunol. 2006, 177:5337-5346.
32. Schmidlin H., Diehl S.A., Blom B. New insights into the regulation of human B-cell differentiation. Trends Immunol. 2009, 30:277-285.
33. Schneider D., Manzan M.A., Crawford R.B., Chen W., Kaminski N.E. 2,3,7,8-Tetrachlorodibenzo-p-dioxin-mediated impairment of B cell differentiation involves dysregulation of paired box 5 (Pax5) isoform, Pax5a. J. Pharmacol. Exp. Ther. 2008, 326:463-474.
34. Schneider D., Manzan M.A., Yoo B.S., Crawford R.B., Kaminski N. Involvement of Blimp-1 and AP-1 dysregulation in the 2,3,7,8-tetrachlorodibenzo-p-dioxin-mediated suppression of the IgM response by B cells. Toxicol. Sci. 2009, 108:377-388.
35. Selgrade M.K. Use of immunotoxicity data in health risk assessments: uncertainties and research to improve the process. Toxicology 1999, 133:59-72.
36. Suh J., Jeon Y.J., Kim H.M., Kang J.S., Kaminski N.E., Yang K.H. Aryl hydrocarbon receptor-dependent inhibition of AP-1 activity by 2,3,7,8-tetrachlorodibenzo-p-dioxin in activated B cells. Toxicol. Appl. Pharmacol. 2002, 181:116-123.
37. Sulentic C.E., Holsapple M.P., Kaminski N.E. Aryl hydrocarbon receptor-dependent suppression by 2,3,7, 8-tetrachlorodibenzo-p-dioxin of IgM secretion in activated B cells. Mol. Pharmacol. 1998, 53:623-629.
38. Sutherland C.L., Heath A.W., Pelech S.L., Young P.R., Gold M.R. Differential activation of the ERK, JNK, and p38 mitogen-activated protein kinases by CD40 and the B cell antigen receptor. J. Immunol. 1996, 157:3381-3390.
39. Tan Z., Chang X., Puga A., Xia Y. Activation of mitogen-activated protein kinases (MAPKs) by aromatic hydrocarbons: role in the regulation of aryl hydrocarbon receptor (AHR) function. Biochem. Pharmacol. 2002, 64:771-780.
40. Tucker A.N., Vore S.J., Luster M.I. Suppression of B cell differentiation by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Mol. Pharmacol. 1986, 29:372-377.
41. van Kooten C., Banchereau J. CD40-CD40 ligand. J. Leukoc. Biol. 2000, 67:2-17.
42. Vos J.G., Van Loveren H. Experimental studies on immunosuppression: how do they predict for man?. Toxicology 1998, 129:13-26.
43. Weiss C., Faust D., Durk H., Kolluri S.K., Pelzer A., Schneider S., Dietrich C., Oesch F., Gottlicher M. TCDD induces c-jun expression via a novel Ah (dioxin) receptor-mediated p38-MAPK-dependent pathway. Oncogene 2005, 24:4975-4983.
44. Wood S.C., Holsapple M.P. Direct suppression of superantigen-induced IgM secretion in human lymphocytes by 2,3,7,8-TCDD. Toxicol. Appl. Pharmacol. 1993, 122:308-313.
45. Wood S.C., Jeong H.G., Morris D.L., Holsapple M.P. Direct effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on human tonsillar lymphocytes. Toxicology 1993, 81:131-143.
46. Yoo B.S., Boverhof D.R., Shnaider D., Crawford R.B., Zacharewski T.R., Kaminski N.E. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) alters the regulation of Pax5 in lipopolysaccharide-activated B cells. Toxicol. Sci. 2004, 77:272-279.